Utah Medical Products (UTMD) Financial Ratios: P/E, ROE & More

Utah Medical Products (UTMD) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Utah Medical Products had a P/E ratio of 15.88 (up from 15.03), return on equity of 9.5% (down from 11.3%), debt-to-equity of 0.00 (unchanged) and a current ratio of 37.62 (up from 25.64). A current ratio of 37.62 means current assets exceed current liabilities. Its dividend yield was 2.18% with a payout ratio of 35.3%.

Utah Medical Products Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Valuation Ratios
P/E Ratio	15.88	15.03	18.38	22.14	24.69	28.42
Forward P/E	17.80	17.80	17.80	17.80	17.80	17.80
P/S Ratio	4.65	5.10	6.09	6.97	7.44	7.28
P/B Ratio	1.50	1.77	2.38	3.19	3.41	2.98
Price/Tangible Book	1.72	2.06	2.79	4.03	4.85	4.75
Price/FCF	12.52	14.28	14.12	17.93	17.68	15.92
Price/OCF	12.20	14.06	13.72	17.25	17.22	15.24
PEG Ratio	1.19	1.19	1.19	1.19	1.19	1.19
Enterprise Value Ratios
EV/Revenue	2.47	2.94	4.34	5.65	6.14	6.19
EV/EBITDA	6.06	6.49	9.43	11.02	11.51	12.50
EV/EBIT	7.47	7.65	12.98	14.93	15.95	19.04
EV/FCF	6.65	8.24	10.06	14.53	14.58	13.54
Profitability & Returns
Return on Equity (ROE)	9.54%	11.29%	13.72%	14.88%	14.09%	10.59%
Return on Assets (ROA)	6.51%	7.62%	8.09%	10.33%	10.38%	7.74%
Return on Invested Capital (ROIC)	29.78%	36.87%	36.91%	36.65%	29.85%	8.37%
Return on Capital Employed (ROCE)	10.60%	13.20%	12.80%	16.80%	16.90%	12.70%
Leverage & Solvency Ratios
Debt/Equity	0.00	0.00	0.00	0.00	0.00	0.00
Debt/EBITDA	0.02	0.02	0.01	0.01	0.02	0.02
Debt/FCF	0.02	0.02	0.01	0.02	0.02	0.02
Liquidity Ratios
Current Ratio	37.62	25.64	22.56	15.09	19.54	16.42
Quick Ratio	34.36	23.18	20.44	13.52	17.65	14.69
Efficiency Ratios
Asset Turnover	0.31	0.32	0.39	0.44	0.43	0.38
Inventory Turnover	1.97	1.82	2.19	2.61	2.83	2.53
Yield & Distribution Ratios
Earnings Yield	6.30%	6.66%	5.44%	4.52%	4.05%	3.52%
FCF Yield	7.99%	7.00%	7.08%	5.58%	5.66%	6.28%
Dividend Yield	2.18%	1.93%	1.41%	1.16%	0.86%	1.46%
Payout Ratio	35.29%	30.71%	25.74%	19.20%	77.53%	38.12%
Buyback Yield	7.51%	3.68%	0.17%	0.46%	0.33%	1.79%
Total Return	9.69%	5.61%	1.57%	1.62%	1.18%	3.25%

Source: Company financial statements from annual and quarterly filings. Data as of Sep 30, 2026. Data sources and methodology

Frequently Asked Questions About Utah Medical Products Financial Ratios

What is Utah Medical Products's P/E ratio?

Utah Medical Products's P/E ratio was 15.88 for fiscal 2025 (period ended Dec 31, 2025). It was 15.03 a year earlier.

What is Utah Medical Products's return on equity?

Utah Medical Products's return on equity (ROE) was 9.5% for fiscal 2025 (period ended Dec 31, 2025). It was 11.3% a year earlier.

What is Utah Medical Products's debt-to-equity ratio?

Utah Medical Products's debt-to-equity ratio was 0.00 for fiscal 2025 (period ended Dec 31, 2025). It was 0.00 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition